May Guo Appointed Vice President Business Development at Biomay
Biomay announces the appointment of May Guo as Vice President Business Development. With over 20 years of experience in the life sciences industry, including six years leading business development in mRNA, pDNA, and gene editing, May brings a wealth of expertise to Biomay. She is passionate about advancing innovations in cancer and rare disease therapeutics and is a vocal advocate for scientific knowledge sharing, actively curating and discussing mRNA/LNP research with the global community.
Before joining Biomay, May Guo served as Chief Commercial Officer at Synthgene/Areterna, an mRNA technology company, and held senior leadership roles including Vice President at ReciBioPharm and Director of Business Development at TriLink BioTechnologies. She holds a bachelor’s degree in chemistry from Peking University and an MBA from Georgetown University.
“We are thrilled to welcome May Guo to our executive team,” said Hans Huber, CEO of Biomay. “Her deep industry knowledge and extensive network will be instrumental in driving our business growth and expanding our global footprint. May is a recognized opinion leader in the mRNA/LNP field. At Biomay, she will strengthen our leadership team and drive innovation. It’s a pleasure having her on board.”
“I am impressed by Biomay’s track record and the company´s state-of-the-art manufacturing facilities and quality systems,” said May Guo. “As an FDA-inspected manufacturer, we are committed to delivering pDNA, mRNA, and recombinant protein products of the highest quality, helping clients succeed in their clinical programs.”